15 Analysts Assess Medtronic: What You Need To Know
Portfolio Pulse from Benzinga Insights
Medtronic (NYSE:MDT) has been analyzed by 15 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $93.33, with a high of $106.00 and a low of $85.00. Recent analyst actions include several rating raises and price target adjustments, reflecting evolving market conditions and company performance. Medtronic's financials show a 2.77% revenue growth, a net margin of 13.16%, but challenges in ROE and ROA compared to industry averages.
October 08, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic has been analyzed by 15 analysts, with a majority holding an indifferent stance. The average 12-month price target has increased to $93.33. Recent analyst actions include several rating raises and price target adjustments, indicating a positive sentiment shift. Medtronic's financials show a 2.77% revenue growth and a strong net margin, but challenges in ROE and ROA.
The analysis by 15 analysts shows a positive shift in sentiment with several rating raises and increased price targets. The average price target has risen, indicating optimism about Medtronic's future performance. Despite some financial challenges, the company's revenue growth and strong net margin support a positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100